Trial Profile
A trial to investigate the effect of dapagliflozin on mediators of ketosis in patients on triple therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2018
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- 20 Mar 2018 Results presented at The 100th Annual Meeting of the Endocrine Society
- 04 Apr 2016 New trial record